Published in Osteoporos Int on December 14, 2004
Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporos Int (2007) 1.04
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02
Calcaneal quantitative ultrasound as a determinant of bone health status: what properties of bone does it reflect? Int J Med Sci (2013) 0.91
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Development of a parametric finite element model of the proximal femur using statistical shape and density modelling. Comput Methods Biomech Biomed Engin (2011) 0.85
Utility of screening tools for the prediction of low bone mass in African American men. Osteoporos Int (2006) 0.85
Differences in age-related bone mass of proximal femur between Chinese women and different ethnic women in the United States. J Bone Miner Metab (2007) 0.84
Nutrient intake and bone health status of Korean male college students as related to smoking situations. Nutr Res Pract (2008) 0.83
Reference data for quantitative ultrasound values of calcaneus in 2927 healthy Chinese men. J Bone Miner Metab (2008) 0.82
Performance of calcaneus quantitative ultrasound and dual-energy X-ray absorptiometry in the discrimination of prevalent asymptomatic osteoporotic fractures in postmenopausal women. Rheumatol Int (2008) 0.81
Physical activity is the strongest predictor of calcaneal peak bone mass in young Swedish men. Osteoporos Int (2009) 0.79
Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis. Osteoporos Int (2006) 0.78
Body composition: gender-specific risk factor of reduced quantitative ultrasound measures in older people. Osteoporos Int (2006) 0.77
The osteoporotic male: overlooked and undermanaged? Clin Interv Aging (2007) 0.76
Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men. Osteoporos Int (2012) 0.76
Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. BMC Musculoskelet Disord (2016) 0.75
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis. Nat Genet (2017) 0.75
Bone mineral density in people living with HIV: a narrative review of the literature. AIDS Res Ther (2017) 0.75
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
Prediction of osteoporotic fractures by postural instability and bone density. BMJ (1993) 2.93
Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet (1996) 2.83
Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1997) 2.50
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res (2003) 1.56
Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res (1998) 1.51
Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom (2004) 1.46
Dual X-ray absorptiometry of hip, heel ultrasound, and densitometry of fingers can discriminate male patients with hip fracture from control subjects: a comparison of four different methods. J Clin Densitom (2002) 1.40
What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom (2002) 1.20
Comparison of bone mineral density and quantitative ultrasound of the calcaneus: site-matched correlation and discrimination of axial BMD status. Br J Radiol (2000) 1.14
Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res (2000) 1.13
Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int (2001) 1.13
The relationship between bone density and incident vertebral fracture in men and women. J Bone Miner Res (2002) 1.08
Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study. J Bone Miner Res (1998) 1.06
Does combining the results from multiple bone sites measured by a new quantitative ultrasound device improve discrimination of hip fracture? J Bone Miner Res (1999) 1.01
Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res (2002) 0.95
Assessing bone density in men. J Bone Miner Res (2000) 0.92
Bone mineral density and vertebral fractures in men. Osteoporos Int (1999) 0.89
Implications in the use of T-scores for the diagnosis of osteoporosis in men. J Clin Densitom (2002) 0.88
Does bone density predict fractures comparably in men and women? Osteoporos Int (2001) 0.87
Osteoporosis in men--consensus is premature. Calcif Tissue Int (2004) 0.84
Quantitative ultrasound of bone in male osteoporosis. Osteoporos Int (2002) 0.80
The combined use of ultrasound and densitometry in the prediction of vertebral fracture. Br J Radiol (1997) 0.78
Ultrasound measurements at the calcaneus in men: differences between healthy and fractured persons and the influence of age and anthropometric features on ultrasound parameters. Osteoporos Int (1999) 0.78
Usefulness of bone quantitative ultrasound in management of osteoporosis in men. J Clin Densitom (2001) 0.77
Does the combination of quantitative ultrasound and dual-energy X-ray absorptiometry improve fracture discrimination? Osteoporos Int (2001) 0.76
Evaluation of quantitative ultrasound and dual X-Ray absorptiometry measurements in women with and without fractures. J Clin Densitom (1999) 0.75
Ability of peripheral bone assessments to predict areal bone mineral density at hip in community-dwelling elderly men. J Clin Densitom (2002) 0.75
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res (2013) 1.68
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J (2007) 1.67
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther (2004) 1.65
Ulnar neuropathy at the elbow in diabetes. Am J Phys Med Rehabil (2009) 1.54
Natriuretic peptides in heart failure: where we are, where we are going. Intern Emerg Med (2010) 1.51
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Menopause (2013) 1.47
Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab (2003) 1.47
Call for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations. Acta Neurochir (Wien) (2015) 1.40
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. Clin Orthop Relat Res (2014) 1.38
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab (2011) 1.35
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol (2007) 1.35
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J Clin Endocrinol Metab (2012) 1.30
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res (2002) 1.29
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab (2012) 1.27
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab (2004) 1.25
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20
Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol (2006) 1.17
The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) (2010) 1.17
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J (2006) 1.15
Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res (2006) 1.13
Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res (2011) 1.09
Aromatase activity and bone homeostasis in men. J Clin Endocrinol Metab (2004) 1.08
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. Eur J Endocrinol (2010) 1.05
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol Appl Pharmacol (2010) 1.04
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J Bone Miner Res (2010) 1.04
Endocrine actions of osteocalcin. Int J Endocrinol (2013) 1.02
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. Thyroid (2008) 1.01
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Eur J Endocrinol (2006) 1.00
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates. Clin Immunol (2009) 0.99
Prevalence of Paget's disease of bone in Italy. J Bone Miner Res (2005) 0.99
Modifications in the papillary thyroid cancer gene profile over the last 15 years. J Clin Endocrinol Metab (2012) 0.98
Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res (2008) 0.98
Vitamin D status and bone turnover in women with acute hip fracture. Clin Orthop Relat Res (2004) 0.98
Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol (2009) 0.98
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Drugs Aging (2007) 0.97
The TARGET project in Tuscany: the first disease management model of a regional project for the prevention of hip re-fractures in the elderly. Clin Cases Miner Bone Metab (2010) 0.93
Tolerability, side effects, and complications of hysterosalpingocontrast sonography (HyCoSy). Fertil Steril (2008) 0.93
Physical activity and bone turnover markers: a cross-sectional and a longitudinal study. Calcif Tissue Int (2008) 0.93
Comparison of a short food-frequency questionnaire and derived indices with a seven-day diet record in Belgian and Italian children. Int J Public Health (2008) 0.93
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. J Bone Miner Res (2007) 0.93
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol (2005) 0.92
Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev (2011) 0.91
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care (2014) 0.91
Recurrence of endometrial polyps. Gynecol Obstet Invest (2014) 0.91
Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. AJR Am J Roentgenol (2006) 0.91
Buckle removal in retinal detachment surgery: a consecutive case series. Acta Biomed (2008) 0.90
Mononeuropathies of the radial nerve: clinical and neurographic findings in 91 consecutive cases. J Electromyogr Kinesiol (2005) 0.90
Herpes zoster of the head and limbs: electroneuromyographic and clinical findings in 158 consecutive cases. Arch Phys Med Rehabil (2002) 0.89
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. J Bone Miner Res (2013) 0.89
Characteristics and familial aggregation of Paget's disease of bone in Italy. J Bone Miner Res (2005) 0.89
Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res (2006) 0.88
Paget's disease of bone in Italy. J Bone Miner Res (2006) 0.88
Clinical characteristics and evolution of giant cell tumor occurring in Paget's disease of bone. J Bone Miner Res (2015) 0.88
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag (2008) 0.88
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Acute Card Care (2014) 0.87
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. Clin Interv Aging (2010) 0.87
Bazedoxifene for the prevention of postmenopausal osteoporosis. Ther Clin Risk Manag (2008) 0.87
Small dose of rituximab for graves orbitopathy: new insights into the mechanism of action. Arch Ophthalmol (2012) 0.87
Malnutrition, infection and arteriovenous fistula failure: is there a link? J Vasc Access (2011) 0.87
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. Am J Cardiol (2006) 0.87
Angiosarcoma after breast-conserving therapy: fine-needle aspiration biopsy, immunocytochemistry, and clinicopathologic correlates. Cancer (2005) 0.86
Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide. J Clin Pathol (2013) 0.86
A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease. J Bone Miner Res (2012) 0.85
Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the TARGET project. Clin Cases Miner Bone Metab (2010) 0.85
Rhabdomyosarcomas: an overview on the experimental animal models. J Cell Mol Med (2012) 0.84
Expanding the phenotype of 22q11 deletion syndrome: the MURCS association. Clin Dysmorphol (2008) 0.84
Bisphosphonates target B cells to enhance humoral immune responses. Cell Rep (2013) 0.83
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics (2005) 0.83
Raloxifene in breast cancer prevention. Expert Opin Drug Saf (2008) 0.83
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases. Urology (2004) 0.83
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism. Front Endocrinol (Lausanne) (2013) 0.83